LNSR logo

LNSR LENSAR Inc

NASDAQ · Medical - Equipment & Services · Healthcare

$8.20
-0.07 (-0.85%)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies desi…

Market Cap: $100.71Mwww.lensar.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 13Aug 13

Quote

Day Range
$8.09 – $8.74
52-Week Range
$4.95 – $12.96
Volume
$263.5K
Market Cap
$100.71M
50-Day Avg
$5.87
200-Day Avg
$8.54
Prev Close
$8.27
Open
$8.72

Valuation & Ratios

P/E Ratio
-4.05
EPS
$-2.87
P/B Ratio
-5.34
P/S Ratio
2.38
Debt/Equity
-0.11
Current Ratio
1.15
Dividend Yield
+0.0%
Gross Margin
+46.4%

Returns & Efficiency

Return on Equity
+131.7%
Return on Assets
-48.0%
FCF Yield
-10.7%
EV/EBITDA
-4.33

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$58.44M$-34.28M$-2.87
2024$53.49M$-31.40M$-2.73
2023$42.16M$-14.38M$-1.31
2022$35.36M$-19.91M$-1.96
2021$34.46M$-19.60M$-2.10

Social Signal Score

51
5d
51
2 mentions
30d
51
2 mentions
60d
51
2 mentions
90d
51
2 mentions
news: 2

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $-0.14 per share

2of 7 quarters beat consensus

Typical surprise -87.5% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$0.10 vs $-0.17beat
  • Fri, May 8$1.56 vs $0.18beat
  • Tue, Mar 31$-0.12 vs $-0.07miss
  • Thu, Nov 6$-0.31 vs $-0.10miss
  • Thu, Aug 7$-0.15 vs $-0.08miss
  • Thu, May 8$-2.32 vs $-0.15miss

Estimates and results for LNSR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

LNSRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsmarketbeat.com·2d ago·Neutral

    LENSAR Q2 Earnings Call Highlights LENSAR NASDAQ: LNSR reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter.

    View source ↗
  • Newsglobenewswire.com·2d ago·Neutral

    …lion Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on key operational initiatives.

    View source ↗